Mcap of seven of top 10 firms falls by Rs 74,603 cr; HDFC Bank biggest laggard
时间:2024-06-26 19:39:50 阅读(143)
The combined market valuation of seven of the top 10 valued firms declined by Rs 74,603.06 crore last week, with HDFC Bank emerging as the biggest laggard.
The BSE benchmark declined 398.6 points or 0.60 per cent last week.
The BSE benchmark declined 398.6 points or 0.60 per cent last week.
ICICI Bank’s market valuation eroded by Rs 12,781 crore to Rs 6,66,512.90 crore and that of Bharti Airtel fell by Rs 11,096.48 crore to Rs 4,86,812.08 crore.
The valuation of Hindustan Unilever tanked Rs 10,396.94 crore to Rs 5,87,902.98 crore and that of ITC skidded by Rs 7,726.3 crore to Rs 5,59,159.71 crore.
The market capitalisation (mcap) of Bajaj Finance declined by Rs 4,935.21 crore to Rs 4,27,996.97 crore and that of Infosys dipped Rs 2,656.13 crore to Rs 5,69,406.39 crore.
However, Reliance Industries added Rs 25,607.85 crore taking its valuation to Rs 17,23,878.59 crore.
The market valuation of TCS jumped Rs 2,579.64 crore to Rs 12,62,134.89 crore and that of State Bank of India climbed Rs 847.84 crore to Rs 5,12,451.22 crore.
In the ranking of top-10 firms, Reliance Industries retained the title of the most valued company followed by TCS, HDFC Bank, ICICI Bank, Hindustan Unilever, Infosys, ITC, State Bank of India, Bharti Airtel and Bajaj Finance.
上一篇:Gold ETFs record Rs 165 crore inflow
下一篇:Yes Bank rating- Hold - Stake sale to lend stability to business
猜你喜欢
- IVCA forms new VC Council, Rajan Anandan named chairman
- Tamil Nadu- Transport workers begin indefinite strike ahead of Pongal, DMK sees AIADMK ‘conspiracy’
- Sugar price climbs to fresh six-year high in US as limited India exports adds to supply worries
- Gold looks vulnerable in short term, wait for correction around 58800; All eyes on US FOMC meeting
- ITC shares gain nearly 2% on Q1 performance, ITC Hotels demerger; should you buy, sell or hold-
- Investors richer by over Rs 5
- Investment via SIP- Volatility on cards in upcoming months; check how to sail through coronavirus
- Sun Pharma’s shares advance on Q2 results; Should you buy, hold or sell the stock-
- India’s economic growth to boost demand of corporates- Fitch Ratings